Week6, 2024
1. Influenza activity is elevated nationally, with regional increases (notably regions 3, 5, and 7) and 15.7% of respiratory specimens testing positive for influenza.
2. Of positive clinical lab specimens, 61.8% were Influenza A and 38.2% were Influenza B, with Influenza A(H1N1)pdm09 as the predominant subtype.
3. Public health labs reported 76.9% of positive specimens as Influenza A and 23.1% as Influenza B; Influenza A subtypes were 59.0% A(H1N1) and 41.0% A(H3N2).
4. Outpatient respiratory illness visits remained high at 4.5% of visits (above the 2.9% baseline) and showed regional variation.
5. Cumulative hospitalization rates reached 54.9 per 100,000, with adults aged 65+ years most affected (147.8 per 100,000).
6. Influenza-related deaths accounted for 0.7% of all deaths, with eight pediatric deaths reported this week (season total: 82).
7. Vaccination remains recommended as activity continues, but specific vaccination trend updates were not noted.
8. No novel influenza viruses were identified, and flu antiviral susceptibility remained high across tested strains.
9. CDC estimates 24 million flu illnesses, 260,000 hospitalizations, and 16,000 deaths to date this season, with co-circulation of respiratory viruses like RSV and COVID-19.
10. Predictions indicate continued flu activity, especially in regions where Influenza B is increasing alongside Influenza A.